微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2.34% | 38.46% | -10% | 26/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 2.6% | 3.59% | 136.36% | 20/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 1.1% | -7.56% | -23.61% | 24/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 1.44% | -74.19% | -14.79% | 34/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 1.69% | -75.86% | -32.67% | 38/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 2.51% | -4.92% | 110.92% | 29/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 1.19% | 1387.5% | -78.67% | 30/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 5.58% | 101.31% | -20.29% | 29/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 7% | 112.36% | 165.15% | 27/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 2.64% | 110.36% | 3200% | 29/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 0.08% | 100.19% | 100.02% | 35/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | -426.73% | -3278.7% | -653.54% | 50/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | -56.63% | -96.7% | -122.17% | 38/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | -25.49% | 17.43% | 40.51% | 46/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | -42.85% | -147.83% | -239.27% | 33/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | -12.63% | 92.42% | 56.13% | 46/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | -28.79% | -346.36% | 6.74% | 34/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | -30.87% | -994.68% | -78.54% | 40/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | -17.29% | -1846.47% | 89.63% | 32/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | -166.72% | -312.06% | -2484.81% | 49/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | -6.45% | 33.37% | -128.72% | 29/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | -2.82% | -280.77% | -384.85% | 31/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 0.99% | -18.85% | 102.45% | 19/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | -40.46% | -975.76% | -317.98% | 45/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | -9.68% | -261.87% | -720.51% | 27/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 1.56% | -58.06% | 27.87% | 23/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 1.22% | -28.65% | -73.59% | 18/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 4.62% | -49.4% | -22.74% | 28/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 5.98% | 13.04% | 60.75% | 15/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 3.72% | 35.27% | 117.54% | 15/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 1.71% | -11.4% | -81.27% | 13/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 9.13% | -4.4% | 72.59% | 19/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 5.29% | -32.53% | 92.36% | 12/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | 2.75% | -48.21% | 42.49% | 15/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 1.93% | -62.08% | -79.79% | 9/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | 9.55% | -65.92% | 21.81% | 16/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | 7.84% | -68.01% | 47.65% | 9/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | 5.31% | -71.33% | 4.32% | 7/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | 5.09% | -44.07% | -81.83% | 2/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |